Authors



Scott W. Lee, MD

Latest:

Resource Utilization With Insulin Pump Therapy for Type 2 Diabetes Mellitus

A retrospective claims analysis of managed care enrollees with type 2 diabetes mellitus showed that insulin pump therapy reduced antidiabetic drug and healthcare resource use.


Elizabeth Babalola, BA

Latest:

Caregiver Presence and Patient Completion of a Transitional Care Intervention

Caregivers' presence during patient recruitment is associated with a greater rate of completion of a post hospital transitional care coaching intervention, particularly among men.


Marco Gambera, PharmD

Latest:

Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in Italy

This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.




Rongsheng Luan, MD, PhD

Latest:

Type 2 Diabetes Mellitus in China: A Preventable Economic Burden

Treatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.


Claudia Salzburg, PhD

Latest:

Attributes Common to Programs That Successfully Treat High-Need, High-Cost Individuals

Many programs attempting to effectively treat high-need, high-cost individuals have not been able to lower spending, improve outcomes, or increase satisfaction. This paper suggests 8 attributes that many successful programs share.



Wayne Katon, MD

Latest:

Population Targeting and Durability of Multimorbidity Collaborative Care Management

Benefits of a patient-centered multimorbidity care management program occurred early, and were evident only among patients with depression and unfavorable medical control of diabetes and heart disease.


Myron Tong, MD

Latest:

Trends in Viral Hepatitis Cost-Effectiveness Studies

Regardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.





Greg E. Simon, MD, MPH

Latest:

A Value Proposition for Pragmatic Clinical Trials

The authors examine the origin, benefits, and challenges of pragmatic clinical trials to assess the ultimate value of this research design.


Kelly Davio

Latest:

Biosimilars at ASH 2019: Data on Truxima and Competitors for Eculizumab

Results for Truxima, recently launched in the United States, and complement inhibitors were presented at the 61st American Society of Hematology Annual Meeting and Exposition.


T. Teresa Dao, MD

Latest:

The FLU-FIT Program: An Effective Colorectal Cancer Screening Program for High Volume Flu Shot Clinics

Offering home fecal immunochemical tests to eligible patients during influenza vaccination clinic increases colorectal cancer screening rates.



Lindsy R. Moore, PharmD

Latest:

Cost-effectiveness Evaluation of a Home Blood Pressure Monitoring Program

A technology-based, pharmacist-run home blood pressure monitoring program improves health outcomes by investing $20.50 per mm Hg systolic blood pressure lowered and $3300 per life-year gained.





Richard Pazdur, MD

Latest:

FDA Oncology Center of Excellence Moves Forward on Coordinated Clinical Reviews, Integrated Approach to the Clinical Evaluation of Oncology Products

An overview of the FDA's Oncology Center of Excellence-a collaborative approach to the clinical approval process.


Satya Surbhi, PhD, MS, BPharm

Latest:

A Mid-South Chronic Disease Registry and Practice-Based Research Network to Address Disparities

The authors report the experience of one of the first Southern US communities to develop a comprehensive health care data repository for tracking processes and outcomes of care and identifying areas of greatest need.


Vishal Goyal, MPH

Latest:

Screening Cardiac Surgery Patients for MRSA: An Economic Computer Model

Routine preoperative MRSA screening of cardiac surgery patients could provide substantial economic value to third-party payers and hospitals under a wide range of circumstances.


Leon E. Cosler, PhD, RPh

Latest:

Variation in the Cost of Medications for the Treatment of Colorectal Cancer

Using data from a nationwide registry, this study revealed significant variation in the use and cost of contemporary regimens for colorectal cancer.


Arun Mohan, MD, MBA

Latest:

Improving Medication Understanding Among Latinos Through Illustrated Medication Lists

A randomized controlled trial found that plain-language, illustrated medication lists improved medication understanding among Latinos.


Victor G. Villagra, MD

Latest:

Health Insurance Literacy: Disparities by Race, Ethnicity, and Language Preference

Racial/ethnic minorities are disproportionately at risk for adverse health and financial consequences due to lower health insurance literacy compared with white enrollees.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo